ASLAN rakes in $43 mln
Singapore-based biotech company ASLAN Pharmaceuticals has raised $43 million in Series C funding. The investors included new backer MVP Capital Partners.
7 January 2016•2 mins read
Singapore-based biotech company ASLAN Pharmaceuticals has raised $43 million in Series C funding. The investors included new backer MVP Capital Partners.
